Tag: Antitoxins

Whitehead Institute scientists have genetically and enzymatically modified red blood cells to carry a range of valuable payloads—from drugs, to ...

Nerve agent sarin bound to bioscavenger enzyme. Courtesy of UT. Researchers at the University of Tennessee at Knoxville (UT) are ...

The U.S. Army Medical Research Institute of Chemical Defense (USAMRICD) hosted its 19th Biennial Medical Defense Bioscience Review, “Advances in ...

FDA’s Medical Countermeasures initiative (MCMi) will host their annual Regulatory Science Symposium this week at FDA Headquarters in Silver Springs, Md. ...

The Department of Defense seeks to identify candidate medical countermeasures and supporting technologies for the Emerging Infectious Diseases Therapeutics (EID ...

The National Institute of Allergy and Infectious Diseases (NIAID) is seeking information from pharmaceutical product developers regarding their efforts toward ...

The National Institute of Allergy and Infectious Diseases (NIAID) Division of Microbiology and Infectious Diseases (DMID) has approved three new ...

The National Institute of Allergy and Infectious Diseases (NIAID) has awarded Hawaii Biotech, Inc. a grant to continue the development ...

Biodefense therapeutics developer PharmAthene, Inc. and Theraclone Sciences, Inc., a privately-held monoclonal antibody (mAb) discovery and development company, last week ...

Elusys Therapeutics, Inc. this week released data from three recently completed studies of ETI-204, an investigational anti-toxin agent in late ...

The Biomedical Advanced Research and Development Authority (BARDA) this week announced a new solicitation for proposals that advance medical countermeasures ...

The U.S. federal government is seeking contractor proposals for the storage and management of a critical medical asset stockpile. The ...

The U.S. Food and Drug Administration last week announced that it has approved Botulism Antitoxin Heptavalent (A, B, C, D, ...

National Institute of Allergy and Infectious Diseases (NIAID) has released a new Broad Agency Announcement (BAA) in support of the ...

The Biomedical Advanced Research and Development Authority (BARDA) has issued a Request for Proposals (RFP) for anthrax antitoxin products to ...

The Biomedical Advanced Research and Development Authority (BARDA) has formally released BARDA-CBRN-BAA-12-100-SOL-00011 for “Advanced Research and Development of Chemical, Biological, Radiological, ...

Biomedical Advanced Research and Development Authority (BARDA) will release a new Broad Agency Announcment (BAA) on 4 March, 2012 for ...